HLA-A2 transgenic mice represent a versatile animal model for preclinical studies of HLA-A*0201 restricted CTL responses and represent a mouse model which is closer than C57BL6 for human cervical cancer. This evidence concerns the gene HLA-A and cervical carcinoma.